logo
Site Network

Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. National Institute of Oncology

+48322788888
onkologia@gliwice.nio.gov.pl
Source: Site record.
http://www.gliwice.nio.gov.pl

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Site Overview

Source: Human-provided.

The National Institute of Oncology Hungary is a leading center for cancer care, research, and education in Hungary. Located in Budapest, it serves as a national reference institution for oncology, providing comprehensive services in cancer diagnosis, treatment, and prevention. The institute offers a wide range of specialized oncology services, including medical oncology, surgical oncology, radiation therapy, and palliative care. It is equipped with modern diagnostic and therapeutic technologies, enabling the management of complex cancer cases. The center is also known for its multidisciplinary approach, ensuring coordinated and personalized treatment plans for patients. In addition to clinical services, the institute plays a significant role in scientific research and innovation, participating in national and international clinical trials. It is also involved in training healthcare professionals and supporting academic development in oncology. By integrating research, education, and…

Business Status

Source: Google. OPEN

Business Category

Source: Google. Cancer treatment center

Business Subcategory

Source: Google. Cancer treatment center
Source: Google. Hospital
Source: Google. Doctor
Source: Trial-derived.
50Total Trials
Source: Trial-derived.
11Recruiting Trials
Source: Trial-derived.
23Active Trials
Source: Trial-derived.
23Completed Trials
Source: Trial-derived.
60Unique Conditions
Source: Trial-derived.
56Unique Sponsors

Conditions

Source: Trial-derived. Breast Cancer (6)Source: Trial-derived. Quality of Life (3)Source: Trial-derived. Chronic Lymphocytic Leukemia (2)Source: Trial-derived. Diffuse Large B-Cell Lymphoma (2)Source: Trial-derived. Mastectomy; Lymphedema (2)Source: Trial-derived. Ovarian Cancer (2)Source: Trial-derived. Patient Satisfaction (2)Source: Trial-derived. Small Lymphocytic Lymphoma (2)

Sponsors

Source: Trial-derived. National Institute of Oncology, Hungary (5)Source: Trial-derived. ETOP IBCSG Partners Foundation (4)Source: Trial-derived. Incyte Corporation (4)Source: Trial-derived. AbbVie (3)Source: Trial-derived. Merck Sharp & Dohme LLC (3)Source: Trial-derived. Breast International Group (2)Source: Trial-derived. Eli Lilly and Company (2)Source: Trial-derived. European Network of Gynaecological Oncological Trial Groups (ENGOT) (2)

Facilities & Operations

Facilities and operational capabilities inferred from trial participation

Source: AI-inferred. Overnight or inpatient research stays supported

Research Technology

Research technology inferred from trial participation

Source: AI-inferred. Telehealth study visits

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Electrocardiography (lead count not stated)
Source: AI-inferred. CT Scan
Source: AI-inferred. MRI
Source: AI-inferred. PET-CT
Source: AI-inferred. 12-lead ECG
Source: AI-inferred. Echocardiography
Source: AI-inferred. Standardised clinical photography
Source: AI-inferred. X-Ray

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Timed pharmacokinetic sampling and processing
Source: AI-inferred. Histology / pathology
Source: AI-inferred. Specimen packaging and shipment
Source: AI-inferred. PCR / molecular
Source: AI-inferred. Immunogenicity (anti-drug antibody) testing
Source: AI-inferred. Pharmacokinetic bioanalysis

Research Pharmacy & Investigational Product

Investigational-product capabilities inferred from trial participation

Source: AI-inferred. Hazardous / cytotoxic drug handling

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration
Source: AI-inferred. Surgery / operating room
Source: AI-inferred. Radiation therapy
Source: AI-inferred. Tumour tissue biopsy (guidance not stated)

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Axillary lymph node clip placement
Source: AI-inferred. HLA typing
Source: AI-inferred. KRAS G12C mutation testing
Source: AI-inferred. Minimal residual disease (MRD) assessment
Source: AI-inferred. Minimal residual disease (MRD) testing
Source: AI-inferred. Peritumoral and perilymphatic injection administration
Source: AI-inferred. Radiographic tumour response assessment
Source: AI-inferred. Subcutaneous infusion administration